Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural Enablement
Applied Research · 2025-02 · 4 (1)
DOI: 10.1002/appl.202400192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Research, online erschienen am 24.11.2024. Verfasst von Daren Fearon und 38 weiteren Autor:innen. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fragment‐based drug discovery is a well‐established method for the identification of chemical starting points for development into clinical candidates. Historically, crystallographic fragment screening was perceived to be low‐throughput and time consuming. However, thanks to advances in synchrotron capabilities and the introduction of dedicated facilities, such as the XChem platform at Diamond Light Source, there have been substantial improvements in throughput and integration between sample preparation, data collection and hit identification. Herein we share our experiences of establishing a crystallographic fragment screening facility, our learnings from operating a user programme for ten years and our perspective on applying structural enablement to rapidly progress initial fragment hits to lead‐like molecules.
Zitieren
APA
Fearon, D., Powell, A., Douangamath, A., Dias, A., Tomlinson, C. W. E., Balcomb, B. H., Aschenbrenner, J. C., Aimon, A., Barker, I. A., Bertram, F., Brandão‐Neto, J., Coe, P. A., Collins, P., Dunnett, L. E., Fairhead, M., Gildea, R. J., Golding, M., Gorrie‐Stone, T., Hathaway, P. V., …, & Delft, F. V. (2025). Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural Enablement. Applied Research, 4(1). https://doi.org/10.1002/appl.202400192
Vancouver
Fearon D, Powell A, Douangamath A, Dias A, Tomlinson CWE, Balcomb BH, et al. Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural Enablement. Applied Research. 2025;4(1). doi:10.1002/appl.202400192
BibTeX
@article{Fearon2025,
author = {Fearon, Daren and Powell, Ailsa and Douangamath, Alice and Dias, Alexandre and Tomlinson, Charles W. E. and Balcomb, Blake H. and Aschenbrenner, Jasmin C. and Aimon, Anthony and Barker, Isabel A. and Bertram, Felicity and Brandão‐Neto, José and Coe, Paul A. and Collins, Patrick and Dunnett, Louise E. and Fairhead, Michael and Gildea, Richard J. and Golding, Mathew and Gorrie‐Stone, Tyler and Hathaway, Paul V. and Koekemoer, Lizbé and Krojer, Tobias and Lithgo, Ryan M. and Maclean, Elizabeth M. and Marples, Peter G. and Mikolajek, Halina and Ni, Xiaomin and Nidamarthi, Kutumbarao H. V. and O'Donnell, Garry and Skyner, Rachael and Talon, Romain and Thompson, Warren and Watt, Grant and Wild, Conor F. and Williams, Mark A. and Winokan, Max and Wright, Nathan David and Winter, Graeme and Shotton, Elizabeth J. and Delft, Frank von},
title = {Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural Enablement},
journal = {Applied Research},
year = {2025},
volume = {4},
number = {1},
doi = {10.1002/appl.202400192}
}
EUVIMED